跳至主要内容
临床试验/ISRCTN10128742
ISRCTN10128742已完成未知

Assessment of the efficacy of a food supplement in improving bone turnover markers and menopause-related symptoms in post-menopausal women: a double blind, randomized clinical study of efficacy and safety.

Paladin Pharma S.p.A.0 个研究点目标入组 60 人开始时间: 2016年4月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37569440/ (added 03/05/2024)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Healthy female subjects; Age: between 50 and 55 years old
  • 2. Caucasian ethnicity
  • 3. Body mass index between 20 and 25
  • 4. Slightly overweight (10-20% than ideal weight)
  • 5. Menopause onset (date of last menstrual cycle) not longer than 1 year from the date of study entry
  • 6. Case history characterized by menopausal syndrome psychological complaints (anxiety, emotional instability, depression), hot flush, localized fat and body fat percentage increase
  • 7. No participation in similar trials
  • 8. Absence of disease
  • 9. Agreement not to make any changes to the normal everyday routine
  • 10. Agreement not to use during the study products with activity similar such than the tested product
  • 11. Agreement not to make any changes to eating habits
  • 12. Subjects informed of the trial procedures who have signed an informed consent form

排除标准

  • 1. Subjects not satisfying the inclusion criteria
  • 2. Subjects under local or systemic pharmacological treatment
  • 3. Subjects who do not have endometrial hyperplasia in their case history
  • 4. Hormone replacement therapy
  • 5. Metabolic syndrome
  • 6. Depressive syndrome not menopause related
  • 7. Subjects with food intolerances

研究者

发起方
Paladin Pharma S.p.A.

相似试验